These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17346704)

  • 1. 5-HT4 receptor and Alzheimer's disease: the amyloid connection.
    Lezoualc'h F
    Exp Neurol; 2007 Jun; 205(2):325-9. PubMed ID: 17346704
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of 5-HT4 receptors inhibits secretion of beta-amyloid peptides and increases neuronal survival.
    Cho S; Hu Y
    Exp Neurol; 2007 Jan; 203(1):274-8. PubMed ID: 16978609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and biological evaluation of new 5-HT4 receptor agonists: application as amyloid cascade modulators and potential therapeutic utility in Alzheimer's disease.
    Russo O; Cachard-Chastel M; Rivière C; Giner M; Soulier JL; Berthouze M; Richard T; Monti JP; Sicsic S; Lezoualc'h F; Berque-Bestel I
    J Med Chem; 2009 Apr; 52(8):2214-25. PubMed ID: 19334715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT(4) receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: A pharmacodynamic and pharmacokinetic assessment.
    Shen F; Smith JA; Chang R; Bourdet DL; Tsuruda PR; Obedencio GP; Beattie DT
    Neuropharmacology; 2011; 61(1-2):69-79. PubMed ID: 21392515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alzheimer's disease and amyloid beta-protein].
    Ikeda S
    No To Shinkei; 1989 Nov; 41(11):1051-64. PubMed ID: 2515890
    [No Abstract]   [Full Text] [Related]  

  • 6. New insights into serotonin 5-HT4 receptors : a novel therapeutic target for Alzheimer's disease?
    Maillet M; Robert SJ; Lezoualc'h F
    Curr Alzheimer Res; 2004 May; 1(2):79-85. PubMed ID: 15975071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the amyloid precursor protein ectodomain shedding by the 5-HT4 receptor and Epac.
    Robert S; Maillet M; Morel E; Launay JM; Fischmeister R; Mercken L; Lezoualc'h F
    FEBS Lett; 2005 Feb; 579(5):1136-42. PubMed ID: 15710402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel m1 muscarinic agonists in treatment and delaying the progression of Alzheimer's disease: an unifying hypothesis.
    Fisher A; Brandeis R; Haring R; Eshhar N; Heldman E; Karton Y; Eisenberg O; Meshulam H; Marciano D; Bar-Ner N; Pittel Z
    J Physiol Paris; 1998; 92(5-6):337-40. PubMed ID: 9789833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct functional effects of human 5-HT4 receptor isoforms on beta-amyloid secretion.
    Robert SJ; Lezoualc'h F
    Neurodegener Dis; 2008; 5(3-4):163-5. PubMed ID: 18322379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of amyloid precursor protein in the mechanisms of neurodegeneration in Alzheimer's disease.
    Masliah E
    Lab Invest; 1997 Sep; 77(3):197-209. PubMed ID: 9314943
    [No Abstract]   [Full Text] [Related]  

  • 11. VRX-03011, a novel 5-HT4 agonist, enhances memory and hippocampal acetylcholine efflux.
    Mohler EG; Shacham S; Noiman S; Lezoualc'h F; Robert S; Gastineau M; Rutkowski J; Marantz Y; Dumuis A; Bockaert J; Gold PE; Ragozzino ME
    Neuropharmacology; 2007 Sep; 53(4):563-73. PubMed ID: 17692343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease. A glycation connection.
    Harrington CR; Colaco CA
    Nature; 1994 Jul; 370(6487):247-8. PubMed ID: 8035868
    [No Abstract]   [Full Text] [Related]  

  • 13. Intracellular amyloid-beta in Alzheimer's disease.
    LaFerla FM; Green KN; Oddo S
    Nat Rev Neurosci; 2007 Jul; 8(7):499-509. PubMed ID: 17551515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin, Alzheimer's disease and cognition: an old story coming of age?
    Epelbaum J; Guillou JL; Gastambide F; Hoyer D; Duron E; Viollet C
    Prog Neurobiol; 2009 Oct; 89(2):153-61. PubMed ID: 19595735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models.
    Mi W; Pawlik M; Sastre M; Jung SS; Radvinsky DS; Klein AM; Sommer J; Schmidt SD; Nixon RA; Mathews PM; Levy E
    Nat Genet; 2007 Dec; 39(12):1440-2. PubMed ID: 18026100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Converging pathways in Alzheimer's disease.
    Glenner GG
    Lab Invest; 1992 Sep; 67(3):271-3. PubMed ID: 1405487
    [No Abstract]   [Full Text] [Related]  

  • 17. The serotonin 5-HT4 receptor and the amyloid precursor protein processing.
    Lezoualc'h F; Robert SJ
    Exp Gerontol; 2003; 38(1-2):159-66. PubMed ID: 12543273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged stress will induce Alzheimer's disease in elderly people by increased release of homocysteic acid.
    Hasegawa T
    Med Hypotheses; 2007; 69(5):1135-9. PubMed ID: 17499446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bridgehead-methyl analog of SC-53116 as a 5-HT4 agonist.
    Becker DP; Flynn DL; Villamil CI
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3073-5. PubMed ID: 15149647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bridging physiology and pathology in AD.
    Kim D; Tsai LH
    Cell; 2009 Jun; 137(6):997-1000. PubMed ID: 19524503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.